Yangwei Xu

592 total citations
12 papers, 440 citations indexed

About

Yangwei Xu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Yangwei Xu has authored 12 papers receiving a total of 440 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Yangwei Xu's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (2 papers). Yangwei Xu is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (3 papers) and Cancer-related gene regulation (2 papers). Yangwei Xu collaborates with scholars based in China, United States and Germany. Yangwei Xu's co-authors include Qingling Zhang, Guifang Zhu, Jian Li, Huilin Niu, Jiahui Xu, Deying Liu, Yun Fu, Jingbo Sun, Yang Yang and Liying Zhao and has published in prestigious journals such as Cancer Research, Human Pathology and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Yangwei Xu

8 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yangwei Xu China	6	231	136	117	111	58	12	440
Wenying Deng China	11	168 0.7×	88 0.6×	123 1.1×	116 1.0×	30 0.5×	34	372
Jianzhuang Ren China	12	180 0.8×	102 0.8×	82 0.7×	88 0.8×	41 0.7×	26	401
Fengsheng Chen China	13	245 1.1×	89 0.7×	104 0.9×	97 0.9×	48 0.8×	44	461
Liangyu Bie China	14	283 1.2×	219 1.6×	163 1.4×	124 1.1×	61 1.1×	29	567
Huilin Niu China	7	213 0.9×	111 0.8×	93 0.8×	34 0.3×	36 0.6×	18	357
Magdalena C. Liebl Germany	8	241 1.0×	94 0.7×	145 1.2×	42 0.4×	54 0.9×	8	408
Tso‐Fu Wang Taiwan	13	135 0.6×	61 0.4×	89 0.8×	67 0.6×	51 0.9×	47	430
Fangfang Tou China	15	319 1.4×	158 1.2×	110 0.9×	64 0.6×	36 0.6×	30	519
Chunhua Ling China	17	422 1.8×	296 2.2×	111 0.9×	112 1.0×	27 0.5×	45	658
Yanyi Xiao China	14	280 1.2×	121 0.9×	121 1.0×	50 0.5×	41 0.7×	22	457

Countries citing papers authored by Yangwei Xu

Since Specialization

Citations

This map shows the geographic impact of Yangwei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangwei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangwei Xu more than expected).

Fields of papers citing papers by Yangwei Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangwei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangwei Xu. The network helps show where Yangwei Xu may publish in the future.

Co-authorship network of co-authors of Yangwei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Yangwei Xu. A scholar is included among the top collaborators of Yangwei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangwei Xu. Yangwei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Xu, Yangwei, Zaisheng Ye, YanYan Li, et al.. (2025). Disrupting Paraspeckle Stability by Targeting WTX–NONO Phase Separation Enhances Chemotherapy Efficacy in Gastric Cancer. Cancer Research. 86(3). 693–711.

Xu, Yangwei, et al.. (2025). WTX-L/β-arrestin2/LCN2 axis controls vulnerability to ferroptosis in gastric cancer. iScience. 28(3). 111964–111964.

Song, Qingxin, Yangwei Xu, Yajie Xie, et al.. (2025). In vitro Isolation and Culturing of Mouse Primary Chondrocytes for Cartilage Biology. Journal of Visualized Experiments.

Sun, Jingbo, Yue Qiu, Yanyan Li, et al.. (2024). CircTBC1D22A inhibits the progression of colorectal cancer through autophagy regulated via miR-1825/ATG14 axis. iScience. 27(3). 109168–109168. 3 indexed citations

Zhang, Qingling, Do H. Kim, Yangwei Xu, Wei Wang, & L. Jeffrey Medeiros. (2021). Clinicopathological features of syncytial variant nodular sclerosis Hodgkin lymphoma. Human Pathology. 119. 105–113. 5 indexed citations

Fu, Yun, Xiaorong Liu, Guifang Zhu, et al.. (2021). Analyzing microsatellite instability and gene mutation in circulating cell-free DNA to monitor colorectal cancer progression. Translational Cancer Research. 10(6). 2812–2821. 6 indexed citations

Li, Jian, Peng Shen, Peirong Zhou, et al.. (2021). Correction to: Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Journal of Experimental & Clinical Cancer Research. 40(1). 46–46.

Xu, Yangwei, Yanyan Li, Yue Qiu, et al.. (2021). LncRNA NEAT1 Promotes Gastric Cancer Progression Through miR-17-5p/TGFβR2 Axis Up-Regulated Angiogenesis. Frontiers in Cell and Developmental Biology. 9. 705697–705697. 22 indexed citations

Fu, Yun, Guifang Zhu, Yangwei Xu, et al.. (2020). Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species. Molecular Medicine Reports. 23(3). 33 indexed citations

10.

Li, Jian, Peng Shen, Peirong Zhou, et al.. (2020). Mir-20a-5p induced WTX deficiency promotes gastric cancer progressions through regulating PI3K/AKT signaling pathway. Journal of Experimental & Clinical Cancer Research. 39(1). 212–212. 43 indexed citations

11.

Jiang, Yuming, Tuanjie Li, Xiaoling Liang, et al.. (2017). Association of Adjuvant Chemotherapy With Survival in Patients With Stage II or III Gastric Cancer. JAMA Surgery. 152(7). e171087–e171087. 106 indexed citations

12.

Xu, Jiahui, Deying Liu, Huilin Niu, et al.. (2017). Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. Journal of Experimental & Clinical Cancer Research. 36(1). 19–19. 222 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact